Ondansetron Hydrochloride Tablet, Film Coated
Product Images NDC 71610-119

3 FDA label images from Aphena Pharma Solutions - Tennessee, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron Hydrochloride (NDC 71610-119). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 8 mg (71610 0119 88)

Bottle Label 8 mg (71610 0119 88)
Label for Ondansetron HCl USP 8 mg tablets, showing a quantity of 900 tablets. The label includes storage instructions, manufacturer information noting Aurobindo Pharma Limited in India, and repackaging details by Aphena Pharma Solutions in Cookeville, Tennessee. It indicates the product is prescription only (RX Only) and includes multiple barcodes and the NDC number 71610-0119-88.*
FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Chemical Structure (Ondansetron Str)

Chemical Structure (Ondansetron Str)
Chemical structure diagram of Ondansetron Hydrochloride, a generic human prescription drug used in an oral film-coated tablet dosage form. The structure includes key functional groups and a hydrochloride dihydrate component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.